14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 0950.HK
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Lee's Pharmaceutical Holdings Limited stock downgraded to Sell Candidate
(Updated on May 17, 2024)

Sell candidate since May 17, 2024 PDF

The Lee's Pharmaceutical Holdings Limited stock price fell by -0.86% on the last day (Friday, 17th May 2024) from HK$1.16 to HK$1.15. During the last trading day the stock fluctuated 2.61% from a day low at HK$1.15 to a day high of HK$1.18. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks. Volume has increased on the last day by 27 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 70 thousand shares were bought and sold for approximately HK$79.93 thousand.

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.61% during the next 3 months and, with a 90% probability hold a price between HK$0.85 and HK$0.99 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

0950.HK Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, April 29, 2024, and so far it has risen 7.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lee's Pharmaceutical Holdings Limited stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at HK$1.17. On a fall, the stock will find some support from the short-term average at HK$1.15. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Lee's Pharmaceutical Holdings Limited gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Lee's Pharmaceutical Holdings Limited stock

Lee's Pharmaceutical Holdings Limited finds support from accumulated volume at HK$1.13 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved HK$0.0300 between high and low, or 2.61%. For the last week, the stock has had daily average volatility of 3.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (0950.HK) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Lee's Pharmaceutical Holdings Limited to open at HK$1.16, and during the day (based on 14 day Average True Range), to move between HK$1.11 and HK$1.19, which gives a possible trading interval of +/-HK$0.0428 (+/-3.73%) up or down from last closing price. If Lee's Pharmaceutical Holdings Limited takes out the full calculated possible swing range there will be an estimated 7.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at HK$1.13 (1.74%) than the resistance at HK$1.18 (2.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lee's Pharmaceutical Holdings Limited stock A Buy?

Lee's Pharmaceutical Holdings Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.697 Sell Candidate Downgraded

Predicted Opening Price for Lee's Pharmaceutical Holdings Limited of Monday, May 20, 2024

Fair opening price May 20, 2024 Current price
HK$1.16 ( 0.87%) HK$1.15

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 0950.HK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.19 3.48 %
R2 1.18 2.48 %
R1 1.17 1.87 %
Current price: 1.15
Support S1 1.15 -0.127 %
S2 1.14 -0.743 %
S3 1.13 -1.74 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.30 13.04 %
R2 1.29 12.17 %
R1 1.18 2.61 %
Current price 1.15
Support S1 1.13 -1.74%
S2 1.08 -6.09%
S3 1.07 -6.96%

0950 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 May 28, 2024 May 28, 2024 Jun 17, 2024 HK$0.0100 0.87%
2 May 25, 2023 May 25, 2023 May 25, 2023 HK$0.0100 0.714%
3 Sep 08, 2022 Sep 08, 2022 Sep 08, 2022 HK$0.0100 0.521%
4 May 26, 2022 May 26, 2022 May 26, 2022 HK$0.0310 1.67%
5 Sep 15, 2021 Sep 15, 2021 Sep 15, 2021 HK$0.0300 0.746%

FAQ

What is the symbol for Lee's Pharmaceutical Holdings Limited Stock and on which exchange is it traded?
The symbol for Lee's Pharmaceutical Holdings Limited is 0950.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell Lee's Pharmaceutical Holdings Limited Stock?
Lee's Pharmaceutical Holdings Limited holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Lee's Pharmaceutical Holdings Limited Stock?
Lee's Pharmaceutical Holdings Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lee's Pharmaceutical Holdings Limited Stock.

What's the current price of Lee's Pharmaceutical Holdings Limited Stock?
As of the end of day on the May 17, 2024, the price of an Lee's Pharmaceutical Holdings Limited (0950.HK) share was HK$1.15.

What is the 52-week high and low for Lee's Pharmaceutical Holdings Limited Stock?
The 52-week high for Lee's Pharmaceutical Holdings Limited Stock is HK$1.75 and the 52-week low is HK$1.00.

What is the market capitalization of Lee's Pharmaceutical Holdings Limited Stock?
As of the May 17, 2024, the market capitalization of Lee's Pharmaceutical Holdings Limited is 677.16M.

When is the next earnings date for Lee's Pharmaceutical Holdings Limited?
The upcoming earnings date for Lee's Pharmaceutical Holdings Limited is Aug 28, 2024.
Click to get the best stock tips daily for free!

About Lee's Pharmaceutical Holdings Limited

Lee's Pharmaceutical Holdings Limited Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. The company focuses on various disease areas, including cardiovascular, woman health, paediatrics, rare diseases, oncology, dermatology, obstetrics, and urology. It operates through Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary a... 0950.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT